Seer
Seer is a life-science company that develops nanoparticle-based, mass spectrometry workflows and complementary data analysis tools to enable deep, unbiased proteomics at scale. The company provides assay workflows, automated sample‑preparation instrumentation, managed LC‑MS services and cloud-enabled analysis software to support large cohort biomarker discovery, proteogenomics and multi-omics studies. Seer also operates a technology access center and partners with external service providers and centers of excellence to deliver projects and samples-to-insight services.
Industries
Nr. of Employees
medium (51-250)
Seer
Patents
Compositions, methods and systems for protein corona analysis and uses thereof
US-12461107-B2
View DetailsSystems and methods for sample preparation, data generation, and protein corona analysis
US-12345715-B2
View DetailsCompositions, methods and systems for protein corona analysis and uses thereof
US-12287331-B2
View DetailsSystems and methods for sample preparation, data generation, and protein corona analysis
US-12241899-B2
View DetailsCompositions, methods and systems for protein corona analysis and uses thereof
US-12222349-B2
View Details
Compositions, methods and systems for protein corona analysis and uses thereof
US-12461107-B2
View DetailsSystems and methods for sample preparation, data generation, and protein corona analysis
US-12345715-B2
View DetailsCompositions, methods and systems for protein corona analysis and uses thereof
US-12287331-B2
View DetailsSystems and methods for sample preparation, data generation, and protein corona analysis
US-12241899-B2
View DetailsCompositions, methods and systems for protein corona analysis and uses thereof
US-12222349-B2
View DetailsProducts
Nanoparticle-based proteomics assay suite
A set of nanoparticle enrichment assays and associated labware for unbiased, high‑sensitivity proteome sampling from biofluids and other sample types; designed for scale and reproducibility.
Automation instrument for sample preparation
An automation platform designed to increase throughput and reproducibility for the nanoparticle-based sample preparation workflows.
Cloud-native proteomics analysis software
Web-hosted analysis platform that performs automated processing, QC, statistical analysis and visualization for proteomics and proteogenomics projects.
Nanoparticle-based proteomics assay suite
A set of nanoparticle enrichment assays and associated labware for unbiased, high‑sensitivity proteome sampling from biofluids and other sample types; designed for scale and reproducibility.
Automation instrument for sample preparation
An automation platform designed to increase throughput and reproducibility for the nanoparticle-based sample preparation workflows.
Cloud-native proteomics analysis software
Web-hosted analysis platform that performs automated processing, QC, statistical analysis and visualization for proteomics and proteogenomics projects.
Services
End-to-end project execution from sample preparation to LC‑MS data and analysis delivered via a technology access center and service provider network.
Managed LC‑MS acquisition services for customer-prepared samples or as part of full-service projects, supporting throughput scaling to thousands of samples.
Software-as-a-service for automated proteomics processing, QC, visualization, group analysis and proteogenomics workflows with optional bioinformatics assistance.
End-to-end project execution from sample preparation to LC‑MS data and analysis delivered via a technology access center and service provider network.
Managed LC‑MS acquisition services for customer-prepared samples or as part of full-service projects, supporting throughput scaling to thousands of samples.
Software-as-a-service for automated proteomics processing, QC, visualization, group analysis and proteogenomics workflows with optional bioinformatics assistance.
Expertise Areas
- Deep, unbiased proteomics
- Proteogenomics and variant peptide identification
- Biomarker discovery and translational proteomics
- High-throughput LC‑MS workflows and operations
Key Technologies
- Nanoparticle-based enrichment
- High-resolution liquid chromatography–mass spectrometry (LC‑MS/MS)
- Data-independent acquisition (DIA) and data-dependent acquisition (DDA)
- Isobaric labeling multiplexing (TMT)
News & Updates
Webinar on integrating large-scale proteomic data with genomic insights for precision medicine (presenters: Claudia Langenberg, PhD and Maik Pietzner, PhD).
Listing for attendance/exhibition at a conference focused on biomarker research (London, UK).
Announcement of a large-scale 20,000-sample proteomics study in collaboration with Korea University aimed at AI-driven cancer diagnostics in young adults.
Announcement of a new workflow release enabling improved scale and efficiency for deep proteomics presented at a scientific meeting.
Information security and medical device quality-management certifications referenced on company site.
Company ranked among fastest-growing technology companies in North America in 2024.
Webinar on integrating large-scale proteomic data with genomic insights for precision medicine (presenters: Claudia Langenberg, PhD and Maik Pietzner, PhD).
Listing for attendance/exhibition at a conference focused on biomarker research (London, UK).
Announcement of a large-scale 20,000-sample proteomics study in collaboration with Korea University aimed at AI-driven cancer diagnostics in young adults.
Announcement of a new workflow release enabling improved scale and efficiency for deep proteomics presented at a scientific meeting.
Information security and medical device quality-management certifications referenced on company site.
Company ranked among fastest-growing technology companies in North America in 2024.